Recent advances in cardiovascular pharmacology

被引:0
作者
Frishman, W
机构
关键词
D O I
10.1016/S0146-2806(00)70011-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:227 / 295
页数:69
相关论文
共 315 条
  • [1] Abraham WT, 1999, CIRCULATION, V100, P299
  • [2] Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable anginal pectoris
    Alpert, JS
    Bakx, ALM
    Braun, S
    Frishman, WH
    Schneeweiss, A
    Tzivoni, D
    Kobrin, I
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (4B) : C20 - C26
  • [3] ALTER M, 1994, STROKE, V25, P1141
  • [4] Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
  • [5] Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection -: The azithromycin in coronary artery disease:: Elimination of myocardial infection with Chlamydia (ACADEMIC) study
    Anderson, JL
    Muhlestein, JB
    Carlquist, J
    Allen, A
    Trehan, S
    Nielson, C
    Hall, S
    Brady, J
    Egger, M
    Horne, B
    Lim, T
    [J]. CIRCULATION, 1999, 99 (12) : 1540 - 1547
  • [6] A RANDOMIZED TRIAL OF LOW-DOSE BETA-BLOCKADE THERAPY FOR IDIOPATHIC DILATED CARDIOMYOPATHY
    ANDERSON, JL
    LUTZ, JR
    GILBERT, EM
    SORENSEN, SG
    YANOWITZ, FG
    MENLOVE, RL
    BARTHOLOMEW, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1985, 55 (04) : 471 - 475
  • [7] MOLECULAR-WEIGHT DEPENDENCY OF THE HEPARIN POTENTIATED INHIBITION OF THROMBIN AND ACTIVATED FACTOR-X - EFFECT OF HEPARIN NEUTRALIZATION IN PLASMA
    ANDERSSON, LO
    BARROWCLIFFE, TW
    HOLMER, E
    JOHNSON, EA
    SODERSTROM, G
    [J]. THROMBOSIS RESEARCH, 1979, 15 (3-4) : 531 - 541
  • [8] [Anonymous], 1989, NEW ENGL J MED, V321, P406
  • [9] [Anonymous], DRUGS FOR THE HEART
  • [10] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]